| Document |
Document Title |
|
WO/2021/214927A1 |
[Problem] To improve the viscosity stability, heat resistance, and dissolution stability of a zinc carboxylic acid salt for the purpose of use by dissolving the zinc carboxylic acid salt in a solvent or dissolving the zinc carboxylic aci...
|
|
WO/2021/213823A1 |
The invention relates to a method for producing a catalytically active multi-element oxide containing Mo, W, V and Cu, wherein an aqueous solution is generated from at least one source of the elementary constituents W of the multi-elemen...
|
|
WO/2021/209486A1 |
The present invention relates to new herbicidally active pyrroline-2-ones according to general formula (I) or agrochemically acceptable salts thereof, and the use of these compounds for controlling weeds and weed grasses in plant crops.
|
|
WO/2021/203206A1 |
The formulation includes CBD and a PPAR agonist. The PPAR agonist can be an omega-3 based PPAR agonist and more specifically can comprise substantially equal parts DHA and EPA.
|
|
WO/2021/205090A1 |
The invention relates to a method for the continuous production of acrylic acid in the absence of an organic solvent and in the absence of a chemical treatment of the aldehydes, and without using a partitioned column, from a gaseous reac...
|
|
WO/2021/203256A1 |
Privided are antifoulant compounds or compositions used for inhibiting or reducing the deposition of ammonium salts.
|
|
WO/2021/204884A1 |
The invention relates to novel herbicidally active 3-phenylpyrrolin-2-ones according to general formula (I) or to agrochemically acceptable salts thereof and to the use thereof for controlling weeds and weed grasses in crops of useful pl...
|
|
WO/2021/200689A1 |
The present invention provides a catalyst which enables the production of isobutylene with high selectivity in cases where isobutylene is produced by means of dehydration of isobutanol. A catalyst according to the present invention conta...
|
|
WO/2021/200795A1 |
The present invention provides a method for producing isobutylene from isobutanol with high selectivity under pressure, while suppressing decrease in the conversion rate of isobutanol. A method for producing isobutylene according to the ...
|
|
WO/2021/198014A1 |
The present invention relates to an improved process for the production of methacrylates, in particular methacrylic acid and/or methyl methacrylate (MMA). Furthermore, the present invention relates to a process and specific embodiments o...
|
|
WO/2021/192861A1 |
An ionic liquid according to the present invention has a structure represented by general formula (1). In general formula (1), R represents a substituted or unsubstituted alkyl group or a substituted or unsubstituted alkenyl group, and a...
|
|
WO/2021/191876A1 |
Methods for the synthesis of methyl 2-fluoroacrylate (MFA) are provided. The methods include use of various hydrofluorination agents using a variety of starting materials and reaction schemes. The methyl 2-fluoroacrylate prepared by the ...
|
|
WO/2021/191042A1 |
Process for inhibiting the undesired free-radical polymerization of acrylic acid present in a liquid phase P, wherein the acrylic acid content of P is at least 10% by weight, the liquid phase P contains in the range from 25 to 1000 ppmw ...
|
|
WO/2021/185879A1 |
A catalytic process for preparing an α,β-ethylenically unsaturated carboxylic acid salt, comprising a) contacting an alkene and carbon dioxide with a carboxylation catalyst, an organic solvent, and an alkoxide having a secondary or ter...
|
|
WO/2021/177343A1 |
Provided is a method in which a caged compound represented by general formula (I) is irradiated with light in the presence of a photosensitizer to thereby release a compound represented by general formula (II). In cases when X is O, th...
|
|
WO/2021/168903A1 |
Provided are an S-substituted-thiosemicarbazone structure compound shown in a formula I and a preparation method and an application thereof. The S-substituted-thiosemicarbazone compound shown in the formula I has an excellent prevention ...
|
|
WO/2021/170397A1 |
The present invention relates to a process for recovering acrylic acid, which is obtained by catalytic gas phase oxidation of propene, wherein, in an absorption stage (K2), the acrylic acid is absorbed out of the reaction mixture (1) of ...
|
|
WO/2021/172423A1 |
The purpose of the present invention is to provide a catalyst capable of improving the selectivity of unsaturated aldehyde and unsaturated carboxylic acid. Provided is a catalyst containing at least molybdenum, antimony, bismuth, and iro...
|
|
WO/2021/172458A1 |
A method for separating water-containing crystals, the method including: a step for generating water-containing crystals from a mixed liquid that contains water, acetic acid, and methacrylic acid; and a step for separating the crystals, ...
|
|
WO/2021/166998A1 |
The present invention provides: a compound represented by general formula (1) or (1') [in the formula, R1 and R2 each independently represent a hydrogen atom or a hydroxy group, R3 represents an alkyl group having 1-6 carbon atoms, R4 re...
|
|
WO/2021/158586A1 |
The present disclosure encompasses a novel solid state form of Blarcamesine and salts thereof, processes for preparation thereof, and pharmaceutical compositions thereof.
|
|
WO/2021/153586A1 |
Trans,trans-muconic acid or an alkyl ester thereof, which serves as a raw material for terephthalic acid or an alkyl ester thereof, is produced by a step in which α-hydromuconic acid or an alkyl ester thereof, which can be derived from ...
|
|
WO/2021/152916A1 |
Provided is a method for producing a catalyst which is used in a gas-phase contact oxidation reaction for producing an unsaturated carboxylic acid such as an acrylic acid and a methacrylic acid from an unsaturated aldehyde such as acrole...
|
|
WO/2021/145233A1 |
[Problem] To provide a method for producing acrylic acid capable of improving the yield of acrylic acid and lengthening the service life of a catalyst in a method in which acrylic acid is produced by gas-phase catalytic oxidation of acro...
|
|
WO/2021/141133A1 |
A catalyst containing molybdenum, bismuth, and cobalt as essential components, wherein in an X-ray diffraction pattern which is obtained using CuKα radiation as an X-ray source, the sum (S) of peak intensity ratios as represented by the...
|
|
WO/2021/141122A1 |
The present invention provides a production method which is capable of stably producing a catalyst that enables the achievement of a methacrylic acid with high selectivity. A method for producing a catalyst for the production of a methac...
|
|
WO/2021/141134A1 |
A catalyst which contains molybdenum, bismuth and cobalt as essential components and has such a property that, with respect to the intensity of a peak at 2θ = 25.3 ± 0.2° in an X-ray diffraction pattern obtained using CuKα line as an...
|
|
WO/2021/134602A1 |
A low sulfur diesel blockage inhibitor as shown in formula (I), a preparation method therefor, and use thereof. In formula (I), x and y are each an integer between 0 and 4; m and n are each an integer between 3 and 9, and 10≤m+n≤14; ...
|
|
WO/2021/130162A1 |
The present invention refers to a co-crystal of Ketoprofen Lysine named Form 4, a pharmaceutical composition comprising said co-crystal, a process for its preparation and to its use in the treatment of pain and inflammatory diseases.
|
|
WO/2021/129082A1 |
The present invention relates to the technical field of organic synthesis, and disclosed is a method for synthesizing an α-acrylic acid compound by using palladium to catalyze carbon dioxide and alkyne. The method comprises: adding an a...
|
|
WO/2021/124272A1 |
The present application discloses a compound of formula (I) or a salt thereof: (I) and compositions comprising such compound or salt thereof. The use of such compound, salt thereof or composition comprising same for treating anemia or le...
|
|
WO/2021/108918A1 |
The invention is related to a method of treating a subject with acute myeloid leukemia, acute lymphoblastic leukemia, chronic myeloid leukemia, non-Hodgkin's lymphoma, Burkitt lymphoma, or diffuse large B-cell lymphoma, or myelodysplasti...
|
|
WO/2021/113635A1 |
Disclosed herein are acylated active agents, compositions containing them, unit dosage forms containing them, and methods of their use, e.g., for treating a metabolic disorder or nonalcoholic fatty liver disease or for modulating a metab...
|
|
WO/2021/103894A1 |
Disclosed are a molybdenum-vanadium composite oxide catalyst, a preparation method therefor and a use thereof. In the catalyst, X is selected from Nb, Sb, Te, Zn, Ca, and Bi; Y is selected from Nd, La, Ce, W, and Cu; and Z is selected fr...
|
|
WO/2021/105038A1 |
The invention relates to a mixture containing (meth)acrylic acid and/or (meth)acrylic acid ester having C1 to C8 alkyl and one or more compounds of the general formula (II) as shelf life- and storage stabilizers.
|
|
WO/2021/105337A1 |
The present invention relates to a process for synthesizing large scale a compound of formula (I), or pharmaceutically acceptable salt thereof, which is useful as the key intermediate for the synthesis of compounds for prophylaxis and tr...
|
|
WO/2021/098885A1 |
Provided are α-fluorochalcone derivatives and an application thereof, the derivatives comprising a pharmaceutically acceptable salt thereof. Also provided is an application for the derivatives and the pharmaceutically acceptable salt th...
|
|
WO/2021/086805A1 |
The present disclosure encompasses solid state forms of Setogepram, in embodiments crystalline polymorphs or salts of Setogepram, particularly Setogepram sodium, processes for preparation thereof, and pharmaceutical compositions thereof.
|
|
WO/2021/073099A1 |
Disclosed is a continuous crystallization process for ibuprofen, wherein an ibuprofen product is obtained by means of multistage continuous crystallization; and the multistage continuous reaction crystallization comprises the steps of re...
|
|
WO/2021/073132A1 |
Application of nervonic acid in the preparation of a pharmaceutical composition for inhibiting generation of melanin or whitening cosmetics for inhibiting generation of melanin. The purity of nervonic acid is greater than 95%, the struct...
|
|
WO/2021/061701A1 |
The present disclosure encompasses solid state forms of Lucerastat, in embodiments crystalline Lucerastat: L-Pyroglutamic acid, crystalline Lucerastat: Salicylic acid, crystalline Lucerastat: Fumaric acid, crystalline Lucerastat: Benzoic...
|
|
WO/2021/059287A1 |
A method of oxygenating a benzylic C-H bond is provided. The method comprises light induced activation of an initiator and subsequent reaction with oxygen, resulting in the formation of free radicals. Subsequently, free radicals catalyze...
|
|
WO/2021/056850A1 |
Provided are an eutectic crystal formed by apixaban and a carboxylic acid, and a preparation method therefor. The eutectic crystal comprises an apixaban/malonic acid eutectic crystal, an apixaban/D‐malate eutectic crystal, an apixaban/...
|
|
WO/2021/061969A1 |
Control methods are disclosed for continuous, unmodulated, multiple catalytic conversion step processes using at least two catalysts, a first catalyst and a second catalyst, that accommodate changes in the performance of each catalyst an...
|
|
WO/2021/055220A1 |
Acrolein is produced by selectively oxidizing allyl alcohol over a first mixed metal oxide catalyst in the presence of oxygen in the vapor phase. The first mixed metal oxide catalyst comprises oxides of molybdenum and bismuth. Acrylic ac...
|
|
WO/2021/047490A1 |
Disclosed in the present invention is a method for preparing dexibuprofen, comprising: (1) after adding toluene into a reaction kettle, adding ibuprofen and n-octyl-d-glucamine, heating to 76 to 80°C, keeping the temperature and reactin...
|
|
WO/2021/042411A1 |
Disclosed are an AKR1C3 inhibitor or a pharmaceutically acceptable salt of same, a preparation method for same, and uses thereof. A structural optimization is performed with a nonsteroidal anti-inflammatory medicament, flurbiprofen, serv...
|
|
WO/2021/036495A1 |
The present invention relates to a novel deuterated 3-pentylphenylacetic acid derivative represented by general formula (I), a preparation method thereof, and a use of a pharmaceutical composition containing the derivative in preparation...
|
|
WO/2021/031756A1 |
Disclosed is a new method for synthesizing carboxylic acid or ketone compounds from an alcohol or corresponding aldehyde using oxygen or oxygen in the air as an oxidant. Under the catalysis of a nitrate/4-hydroxy-2,2,6,6-tetramethylpiper...
|
|
WO/2021/029422A1 |
Provided are a radiation-sensitive composition and method for forming a resist pattern which make it possible to form a resist pattern having excellent sensitivity, excellent resolution, and excellent LWR characteristics. The radiation-s...
|
